Pseudoephedrine-induced toxic epidermal necrolysis [4]

Archives of Dermatology

Volumn 141, Issue 7, 2005, Pages 907-908

  Nagge, Jeffrey J ^a   Knowles, Sandra R ^b   Juurlink, David N ^b   Shear, Neil H ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DEXTROMETHORPHAN; PREDNISONE; PSEUDOEPHEDRINE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; EDEMA; FEMALE; HUMAN; LABORATORY TEST; LETTER; LIP DISEASE; MEDICAL EXAMINATION; OROPHARYNX; PATCH TEST; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RASH; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS; ULCER;

EPHEDRINE; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PATCH TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 23044483812     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.7.907     Document Type: Letter

References (4)

1. Ring J, Thewes M. The clinical expression of allergy in the skin. Allergy. 1999; 54:192-197.
2. Alonso R, Enrique E, Cistero A. Positive patch test to diclofenac in Stevens-Johnson syndrome. Contact Derm. 2000;42:367.
3. Fontaine JF, Lavaud F, Deslee G, Caillet MJ, Lebargy F. Toxic dermatitis caused by pseudoephedrine: apropos of a case [in French]. Allerg Immunol (Paris). 2002;34:230-232.
4. Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol. 1987;123:1160-1165.